Bioactive parathyroid hormone in canine progressive renal insufficiency

Area of Science:

• Endocrinology
• Nephrology
• Metabolic Bone Disease

Background:

• Hyperparathyroidism is a common complication of chronic kidney disease.
• Understanding the role of bioactive parathyroid hormone (PTH) in renal failure progression is crucial.
• Canine models offer insights into human renal failure pathophysiology.

Purpose of the Study:

• To monitor bioactive PTH levels and hormonal actions during progressive canine renal failure.
• To investigate the characteristics of circulating bioactive PTH in uremia.
• To correlate changes in bioactive PTH with renal phosphate handling and skeletal resorption.

Main Methods:

• Progressive renal failure was induced in a canine model.
• Circulating bioactive and immunoreactive PTH levels were measured.
• Gel filtration analysis characterized PTH moieties.
• Renal phosphate threshold, urinary hydroxyproline, and plasma 1,25-dihydroxyvitamin D were assessed.

Main Results:

• Bioactive and immunoreactive PTH levels progressively increased with worsening renal insufficiency.
• Elevated bioactive PTH was most pronounced in the terminal stages of uremia.
• A smaller-molecular-weight bioactive PTH entity appeared in severe renal failure.
• Renal phosphate threshold decreased, and urinary hydroxyproline corrected for GFR increased.
• Plasma 1,25-dihydroxyvitamin D levels fell but remained detectable.

Conclusions:

• Progressive canine renal failure is associated with a marked increase in bioactive PTH.
• A novel smaller-molecular-weight bioactive PTH form emerges in severe renal disease.
• Rising bioactive PTH correlates with impaired renal phosphate handling and increased skeletal resorption.